-
Product Insights
Carotid and Renal Artery Stents Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Carotid and Renal Artery Stents Pipeline Market Report Overview Carotid artery stents are expandable tubes that are implanted in narrowed carotid arteries to increase the flow of blood. Likewise, renal artery stents are expandable tubes that are implanted to increase blood flow in the narrowed renal artery. The Carotid and Renal Artery Stents pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sirolimus in Bronchiolitis Obliterans
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus in Bronchiolitis Obliterans report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Sirolimus in Bronchiolitis Obliterans Drug Details: Sirolimus is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sirolimus in Lymphangioleiomyomatosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus in Lymphangioleiomyomatosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sirolimus in Lymphangioleiomyomatosis Drug Details: Sirolimus is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sirolimus in Pulmonary Arterial Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus in Pulmonary Arterial Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sirolimus in Pulmonary Arterial Hypertension Drug Details: Sirolimus is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sirolimus in Pulmonary Sarcoidosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus in Pulmonary Sarcoidosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sirolimus in Pulmonary Sarcoidosis Drug Details: Sirolimus is under development for the...
-
Product Insights
External Remote Patient Monitoring Devices Pipeline by Development Stages, Segments, Countries, Regulatory Path and Key Companies
External Remote Patient Monitoring Devices Pipeline Market Report Overview An External Remote Patient Monitoring Device retrieves the data from the external measurement device such as glucose meters. The device then transmits the data through a wireless system to a monitoring station or a physician’s office for further analysis and interpretation. The External Remote Patient Monitoring Devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report...
-
Product Insights
Vascular Access Devices for Hemodialysis Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Vascular Access Devices for Hemodialysis Pipeline Market Report Overview Vascular Access Devices for Hemodialysis include AV Fistula Needles, Grafts, Vascular Covered Stents, and Hemodialysis Catheters. The Vascular Access Devices for Hemodialysis pipeline market research report provides comprehensive information about the Vascular Access Devices for Hemodialysis pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Territories ·       The US ·       China ·       Europe ·       Global...
-
Sector Analysis
Contract Pharmaceutical Dose Manufacturing Industry – Composition, Size, Market Share and Outlook, 2023 Edition
Contract Pharmaceutical Dose Manufacturing Industry Overview The total dose CMO contract revenue in 2022 represented significant growth over 2021 revenue. The growth rate was the highest recorded since 2011 for commercial contract dose manufacturing revenues, and surprisingly adds to the strong growth experienced in 2021, despite demand for COVID-19 vaccines and therapies waning in 2022. The Contract Pharmaceutical Dose Manufacturing Industry report is a comprehensive look at the finished dose contract manufacturing landscape in 2023. It includes an analysis of...
-
Product Insights
United Kingdom (UK) Protection Insurance – Income Protection Market
United Kingdom (UK) Protection Insurance – Income Protection Market Report Overview The income protection (IP) market experienced strong growth in 2022. Contracts increased to 213,100, while premiums generated from these contracts was GBP81 million in 2022. The number of IP contracts is expected to witness a surge during the projected period as consumers gain confidence due to minimizing inflation, falling interest rates, and the improving economy. This will further result in the IP premiums growing at a CAGR of more...